Research suggests that amygdalin may help promote cell death in cancer cells by increasing the expression of proapoptotic proteins and caspase-3 while reducing the expression of anti-apoptotic proteins. When combined with immunotherapies, amygdalin shows even greater potential as a supportive anti-cancer therapy. We have been using amygdalin as part of our metabolic approach to treating cancer, and we continue to see promising results.